Innospec Inc. (NASDAQ:IOSP) Given Consensus Rating of “Hold” by Analysts

Innospec Inc. (NASDAQ:IOSP) has been given an average rating of “Hold” by the three ratings firms that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and one has assigned a strong buy recommendation to the company.

A number of equities research analysts recently commented on the company. Zacks Research upgraded Innospec from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Wall Street Zen lowered Innospec from a “buy” rating to a “hold” rating in a research report on Sunday, October 19th. Finally, Weiss Ratings lowered Innospec from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Saturday, October 25th.

Innospec Trading Down 1.9%

IOSP stock opened at $72.26 on Friday. Innospec has a 1-year low of $71.82 and a 1-year high of $128.35. The firm has a market cap of $1.79 billion, a P/E ratio of 92.64 and a beta of 1.04. The business’s 50 day moving average is $78.99 and its 200-day moving average is $83.51.

Innospec (NASDAQ:IOSP) last released its quarterly earnings results on Tuesday, November 4th. The specialty chemicals company reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $1.03 by $0.09. The business had revenue of $441.90 million for the quarter, compared to analyst estimates of $443.00 million. Innospec had a return on equity of 10.89% and a net margin of 1.08%.Innospec’s revenue for the quarter was down .3% on a year-over-year basis. During the same period in the prior year, the company earned $1.35 EPS. Sell-side analysts forecast that Innospec will post 6.18 EPS for the current year.

Institutional Investors Weigh In On Innospec

Large investors have recently bought and sold shares of the business. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new position in Innospec in the 2nd quarter valued at $28,000. EverSource Wealth Advisors LLC boosted its position in Innospec by 1,159.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 529 shares of the specialty chemicals company’s stock valued at $44,000 after buying an additional 487 shares during the last quarter. Versant Capital Management Inc boosted its position in Innospec by 378.1% in the 3rd quarter. Versant Capital Management Inc now owns 545 shares of the specialty chemicals company’s stock valued at $42,000 after buying an additional 431 shares during the last quarter. Blue Trust Inc. boosted its position in Innospec by 38.3% in the 2nd quarter. Blue Trust Inc. now owns 672 shares of the specialty chemicals company’s stock valued at $57,000 after buying an additional 186 shares during the last quarter. Finally, State of Wyoming boosted its position in Innospec by 27.5% in the 2nd quarter. State of Wyoming now owns 801 shares of the specialty chemicals company’s stock valued at $67,000 after buying an additional 173 shares during the last quarter. 96.64% of the stock is currently owned by institutional investors.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.